Literature DB >> 24123344

Implications of high antifungal susceptibility on Schizophyllum commune-associated allergy in clinical practice.

Haruhiko Ogawa1, Masaki Fujimura, Noriyuki Ohkura, Koichi Makimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24123344      PMCID： PMC3811255          DOI： 10.1128/AAC.01657-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  The influence of Schizophyllum commune on asthma severity.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Lung       Date:  2011-10-18       Impact factor: 2.584

2.  Hypothesis for future management of Schizophyllum allergy in asthma control.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Pulm Pharmacol Ther       Date:  2012-04-02       Impact factor: 3.410

3.  Chronic maxillary sinusitis associated with the mushroom Schizophyllum commune in a patient with AIDS.

Authors:  J Rosenthal; R Katz; D B DuBois; A Morrissey; A Machicao
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

5.  The definitive diagnostic process and successful treatment for ABPM caused by Schizophyllum commune: a report of two cases.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura; Kazuo Satoh
Journal:  Allergol Int       Date:  2012-03       Impact factor: 5.836

6.  Schizophyllum commune: an unusual isolate from a patient with allergic fungal sinusitis.

Authors:  S Clark; C K Campbell; A Sandison; D I Choa
Journal:  J Infect       Date:  1996-03       Impact factor: 6.072

7.  Two cases of Schizophyllum asthma: is this a new clinical entity or a precursor of ABPM?

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Pulm Pharmacol Ther       Date:  2011-04-30       Impact factor: 3.410

Review 8.  Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview.

Authors:  Anuradha Chowdhary; Kshitij Agarwal; Shallu Kathuria; Shailendra Nath Gaur; Harbans Singh Randhawa; Jacques F Meis
Journal:  Crit Rev Microbiol       Date:  2013-02-05       Impact factor: 7.624

9.  Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.

Authors:  David W Denning; B Ronan O'Driscoll; Georgina Powell; Fiona Chew; Graham T Atherton; Aashish Vyas; John Miles; Julie Morris; Robert M Niven
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

10.  Impact of Schizophyllum sensitization on decline of lung function in asthma.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  J Asthma       Date:  2013-06-18       Impact factor: 2.515
  10 in total
  1 in total

1.  Schizophyllum radiatum, an Emerging Fungus from Human Respiratory Tract.

Authors:  J P Z Siqueira; D Sutton; J Gené; D García; M Guevara-Suarez; C Decock; N Wiederhold; J Guarro
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.